Get the Stockscreener App
11.64
9.63%
-1.24
After Hours:
11.69
0.05
+0.43%
Hyperion Defi Inc stock is traded at $11.64, with a volume of 763.96K.
It is down -9.63% in the last 24 hours and up +0.00% over the past month.
Hyperion DeFi Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or new combinations.
See More
Previous Close:
$12.88
Open:
$13.14
24h Volume:
763.96K
Relative Volume:
8.56
Market Cap:
$61.75M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$11.59
$13.30
1-Week Range:
$11.00
$16.12
52-Week Range:
$11.00
$16.12
Hyperion Defi Inc Stock (HYPD) Company Profile
Name
Hyperion Defi Inc
Sector
Industry
Phone
813-766-9539
Address
295 MADISON AVENUE,, NEW YORK
Compare HYPD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HYPD
Hyperion Defi Inc
|
11.64 | 61.41M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Hyperion Defi Inc Stock (HYPD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-18-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-01-21 | Initiated | Northland Capital | Outperform |
| Feb-03-20 | Downgrade | Oppenheimer | Outperform → Perform |
Hyperion Defi Inc Stock (HYPD) Latest News
Hyperion DeFi Inc (HYPD) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
Hyperion DeFi, Inc.Common Stock (Nasdaq:HYPD) Stock Quote - FinancialContent
Hyperion DeFi, Inc. to Host Corporate Update Event on Transition to Decentralized Finance Strategy - Nasdaq
First US Public Company Transforms to DeFi: Hyperion Unveils 1.4M HYPE Token Strategy - Stock Titan
Why Did Defi Development Corp. (DFDV) Soar 12.07%? - AInvest
Captivision Inc Inc. (CAPT) Price Performance: The Role of Supply and Demand - investchronicle.com
IRBT’s Stock Market Adventure: -43.71% YTD Growth Amidst Volatility - investchronicle.com
Hyperion DeFi adds 120,726 HYPE tokens to its strategic holdings By Investing.com - Investing.com Nigeria
Hyperion DeFi adds 120,726 HYPE tokens to its strategic holdings - Investing.com Australia
Hyperion DeFi Adds $5 Million in HYPE to its Treasury Holdings - The Manila Times
Nasdaq-Listed Hyperion DeFi Adds $5M in HYPE Tokens, Grows Treasury to 1.4M Tokens - Stock Titan
Why Did Hyperion DeFi Soar 13.23%? - AInvest
Hyperion DeFi shares rise 6.91% premarket after name and ticker change announcement. - AInvest
Hyperion DeFi (HYPD) 10K Form and SEC Filings 2025 - MarketBeat
Hyperion DeFi shares rise 5.71% premarket after name and ticker change announcement. - AInvest
Eyenovia rebrands as Hyperion DeFi, Inc with new focus - Eyes On Eyecare
Eyenovia Announces Rebranding and Corporate Name Change to Hyperion DeFi, Inc. - VisionMonday.com
Hyperion DeFi: A Nasdaq-Backed Leap into the DeFi Treasury Frontier? - AInvest
Hyperion DeFi stock soars after company rebrands from Eyenovia - Investing.com Australia
Eyenovia Announces Rebranding and Corporate Name Change to Hyper - GuruFocus
Eyenovia Inc Rebrands as Hyperion DeFi - Investing.com India
Eyenovia Inc Rebrands as Hyperion DeFi By Investing.com - Investing.com Canada
Eyenovia, Inc. Rebrands to Hyperion DeFi, Inc. and Announces Nasdaq Trading Under “HYPD” Ticker - Quiver Quantitative
Eyenovia Rebrands to Hyperion DeFi, Focuses on Crypto - TipRanks
Eyenovia Adds $10 Million in HYPE to its Treasury Holdings in Preparation for Strategic Onchain Engagement - GlobeNewswire
Eyenovia Announces Co-Branded Validator with Kinetiq - GlobeNewswire
Eyenovia Soars 12.23% on Crypto Rebranding - AInvest
Eyenovia Announces Closing of $50 Million Private Placement, Successful Accumulation of More Than One Million HYPE Tokens, and Update on its Optejet Development Program - TradingView
Eyenovia’s $50 Million HYPE Treasury Strategy Is A Bold Bet On DeFi’s Future - Tekedia
Eyenovia to invest $50M in Hyperliquid tokens - MSN
Crypto Market Sees Public Firms Deploy $844M Into Bitcoin and HYPE - The Coin Republic
Eyenovia to acquire $50 million in HYPE cryptocurrency tokens - Investing.com
Eyenovia Provides Updates on Potential Merger with Betaliq - GlobeNewswire
EYENEyenovia Inc Latest Stock News & Market Updates - Stock Titan
Eyenovia proposes merger with Betaliq to form glaucoma company - Eyes On Eyecare
Eyenovia stock falls on reverse merger plans (EYEN:NASDAQ) - Seeking Alpha
Eyenovia Escapes Delisting Threat: What's Next for the Optejet Developer? - Stock Titan
TECLens secures $9.3M Series A funding to advance its non-invasive refractive technology - Eyes On Eyecare
Eyenovia, Inc. Announces Progress on Next-Generation User-Filled Optejet Dispensing Device - MarketScreener
Eyenovia Announces Leading Proxy Advisory Firms, ISS and - GlobeNewswire
Eyenovia to end eye drug study, cut 50% of its workforce - MarketScreener
Eyenovia, Inc. Announces Chief Financial Officer Changes - MarketScreener
EyeCare Partners names new CEO - Eyes On Eyecare
Transcript : Eyenovia, Inc., Q3 2023 Earnings Call, Nov 13, 2023 - MarketScreener
Eyenovia, Inc. Announces First Commercial Sale of Mydcombi - MarketScreener
Hyperion Defi Inc Stock (HYPD) Financials Data
There is no financial data for Hyperion Defi Inc (HYPD). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.87%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):